IFNG expression	Colorectal Cancer	IFNG expression	Colorectal Cancer	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3	M7824 Sensitive: C3 – Early Trials M7824 Sensitive : C3
IFNG expression	Bladder Cancer	IFNG expression	Bladder Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
IFNG expression	Nasopharyngeal Carcinoma	IFNG expression	Nasopharyngeal Carcinoma	PDR001 Sensitive: C3 – Early Trials PDR001 Sensitive : C3	PDR001 Sensitive: C3 – Early Trials PDR001 Sensitive : C3
IFNG expression	Urothelial Cancer	IFNG expression	Urothelial Cancer	PD-L1 inhibitor Sensitive: C3 – Early Trials PD-L1 inhibitor Sensitive : C3	PD-L1 inhibitor Sensitive: C3 – Early Trials PD-L1 inhibitor Sensitive : C3

IFNG expression

Associations